Hye-kyung K. Jung
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
Letter: P-CABs Versus PPIs for Gastroprotection During Antithrombotic Therapy: What Does Treatment Switching Tell us? Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: August 24, 2026
Letter: Interpreting P-CAB Superiority for Antithrombotic Gastroprotection Beyond Acid Suppression. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 23, 2026
Editorial: Prevention of Upper GI Bleeding in Users of Anti-Thrombotic Drugs-P-CABs Versus PPIs. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: May 21, 2026
Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition
Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Published: April 14, 2026
Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition.
Journal: The Korean journal of helicobacter and upper gastrointestinal research
Published: April 13, 2026
P-CAB vs. PPI for Upper Gastrointestinal Bleeding Prevention in Patients With Atherothrombotic Disease on Antithrombotic Therapy: A CDM Cohort Study.
Journal: Alimentary pharmacology & therapeutics
Published: April 02, 2026
Prior Cancer and Survival in Patients With Esophageal Squamous Cell Carcinoma.
Journal: JAMA network open
Published: February 20, 2026
Treatment of Helicobacter pylori Infection in Korea: An Evidence-Based Analysis of the Upcoming 2025 Guideline.
Journal: The Korean journal of helicobacter and upper gastrointestinal research
Published: December 01, 2025
The 2020 disease burden and economic implications of digestive diseases in Korea: a nation-wide comprehensive study.
Journal: The Korean journal of internal medicine
Published: November 05, 2025
2025 Focused Update of the Seoul Consensus on Gastroesophageal Reflux Disease: Evidence-based Recommendations on Acid Suppressive Therapy.
Journal: Journal of neurogastroenterology and motility
Published: July 16, 2025
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.
Journal: Gut and liver
Published: July 09, 2025
Last Updated: 09/26/2026